Source:http://linkedlifedata.com/resource/pubmed/id/15367421
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
2004-9-15
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0923-7534
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
15
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1575-6
|
| pubmed:meshHeading |
pubmed-meshheading:15367421-Antimetabolites, Antineoplastic,
pubmed-meshheading:15367421-Carcinoma,
pubmed-meshheading:15367421-Deoxycytidine,
pubmed-meshheading:15367421-Hemolytic-Uremic Syndrome,
pubmed-meshheading:15367421-Humans,
pubmed-meshheading:15367421-Male,
pubmed-meshheading:15367421-Middle Aged,
pubmed-meshheading:15367421-Neoplasm Recurrence, Local,
pubmed-meshheading:15367421-Pancreatic Neoplasms
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Gemcitabine and haemolytic-uraemic syndrome.
|
| pubmed:publicationType |
Letter,
Case Reports
|